Heat shock protein 27 is associated with irinotecan resistance in human colorectal cancer cells

FEBS Letters

Volumn 581, Issue 8, 2007, Pages 1649-1656

  Choi, Dae Hwa ^a   Ha, Jin Sook ^a,b   Lee, Won Hyuck ^b   Song, Jeong Kee ^b   Kim, Gyu Yeol ^a   Park, Jae Hoo ^a   Cha, Hee Jeong ^a   Lee, Byung Ju ^b   Park, Jeong Woo ^b  

^a Ulsan University College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

Author keywords

Hsp27; Human colorectal cancer cells; Irinotecan resistance

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CASPASE 3; FLUOROURACIL; FOLINIC ACID; HEAT SHOCK PROTEIN 27; IRINOTECAN;

ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; STAINING; STUDENT T TEST; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMPTOTHECIN; CASPASE 3; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; UP-REGULATION;

EID: 34047132772     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.02.075     Document Type: Article

References (41)

1. Wasserman E., Sutherland W., and Cvitkovic E. Irinotecan plus oxaliplatin: a promising combination for advanced colorectal cancer. Clin. Colorectal Cancer 1 (2001) 149-153
2. Chen A.Y., and Liu L.F. DNA topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol. 36 (1994) 191-218
3. Pommier Y. Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecins. Semin. Oncol. 23 (1996) 3-10
4. Calvo E., Cortes J., Rodriguez J., Fernandez-Hidalgo O., Rebollo J., Martin-Algarra S., Garcia-Foncillas J., Martinez-Monge R., de Irala J., and Brugarolas A. Irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin combination chemotherapy in advanced colorectal carcinoma: a Phase II study. Clin. Colorectal Cancer 2 (2002) 104-110
5. Rasheed Z.A., and Rubin E.H. Mechanisms of resistance to topoisomerase I-targeting drugs. Oncogene 22 (2003) 7296-7304
6. Soti C.S., and Csermely P. Molecular chaperones in the etiology and therapy of cancer. Pathol. Oncol. Res. 4 (1998) 316-321
7. Jolly C., and Morimoto R.I. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J. Natl. Cancer Res. Inst. 92 (2000) 1564-1572
8. Garrido C., Fromentin A., Bonnotte B., Favre N., Moutet M., Arrigo A.P., Mehlen P., and Solary E. Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cells. Cancer Res. 58 (1998) 5495-5499
9. Garrido C., Ottavi P., Fromentin A., Hammann A., Arrigo A.P., Chauffert B., and Mehlen P. HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res. 57 (1997) 2661-2667
10. Nylandsted J., Rohde M., Brand K., Bastholm L., Elling F., and Jaattela M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc. Natl. Acad. Sci. USA 97 (2000) 7871-7876
11. Akalin A., Elmore L.W., Forsythe H.L., Amaker B.A., McCollum E.D., Nelson P.S., Ware J.L., and Holt S.E. A novel mechanism for chaperone-mediated telomerase during prostate cancer progression. Cancer Res. 61 (2001) 4791-4796
12. Bruey J.M., Ducasse C., Bonniaud P., Ravagnan L., Susin S.A., Diaz-Latoud C., Gurbuxani S., Arrigo A.P., Kroemer G., Solary E., and Garrido C. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat. Cell Biol. 2 (2000) 645-652
13. Beere H.M., Wolf B.B., Cain K., Mosser D.D., Mahboubi A., Kuwana T., Tailor P., Morimoto R.I., Cohen G.M., and Green D.R. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2 (2000) 469-475
14. Saleh A., Srinivasula S.M., Balkir L., Robbins P.D., and Alnemri E.S. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat. Cell Biol. 2 (2000) 476-483
15. Pandey P., Saleh A., Nakazawa A., Kumar S., Srinivasula S.M., Kumar V., Weichselbaum R., Nalin C., Alnemri E.S., Kufe D., and Kharbanda S. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J. 19 (2000) 4310-4322
16. Garrido C., Gurbuxani S., Ravagnan L., and Kroemer G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem. Biophys. Res. Commun. 286 (2001) 433-442
17. Garrido C., Bruey J.M., Fromentin A., Hammann A., Arrigo A.P., and Solary E. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J. 13 (1999) 2061-2070
18. Huot J., Roy G., Lambert H., Chretien P., and Landry J. Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein. Cancer Res. 51 (1991) 5245-5252
19. Oesterreich S., Hilsenbeck S.G., Ciocca D.R., Allred D.C., Clark G.M., Chamness G.C., Osborne C.K., and Fuqua S.A. The small heat shock protein 27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients. Clin. Cancer Res. 2 (1996) 1199-1206
20. Yamamoto K., Okamoto A., Isonishi S., Ochiai K., and Ohtake Y. Heat shock protein 27 was up-regulated in cisplatin resistant human ovarian tumor cell line and associated with the cisplatin resistance. Cancer Lett. 168 (2001) 173-181
21. Oesterreich S., Hickey E., Weber L.A., and Fugua S.A. Basal regulatory elements of the hsp27 gene in human breast cancer cells. Biochem. Biophys. Res. Commun. 222 (1996) 155-163
22. Lee B.J., Cho G.J., Norgren Jr. R.B., Junier M.P., Hill D.F., Tapia V., Costa M.E., and Ojeda S.R. TTF-1, a homeodomain gene required for diencephalic morphogenesis, is postnatally expressed in the neuroendocrine brain in a developmentally regulated and cell-specific fashion. Mol. Cell. Neurosci. 17 (2001) 107-126
23. Samali A., Robertson J.D., Peterson E., Manero F., van Zeijl L., Paul C., Cotgreave I.A., Arrigo A.P., and Orrenius S. Hsp27 protects mitochondria of thermotolerant cells against apoptotic stimuli. Cell Stress Chaperon 6 (2001) 49-58
24. Concannon C.G., Gorman A.M., and Samali A. On the role of Hsp27 in regulating apoptosis. Apoptosis 8 (2003) 61-70
25. Schmitt E., Sane A.T., and Bertrand R. Activation and role of caspases in chemotherapy-induced apoptosis. Drug Resist. Update 2 (1999) 21-29
26. Love S., and King R.J. A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Br. J. Cancer 69 (1994) 743-748
27. Oesterreich S., Weng C.N., Qiu M., Hilsenbeck S.G., Osborne C.K., and Fuqua S.A. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res. 53 (1993) 4443-4448
28. Cornford P.A., Dodson A.R., Parsons K.F., Desmond A.D., Woolfenden A., Fordham M., Neoptolemos J.P., Ke Y., and Foster C.S. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res. 60 (2000) 7099-7105
29. Ehrenfried J.A., Herron B.E., Townsend Jr. C.M., and Evers B.M. Heat shock proteins are differentially expressed in human gastrointestinal cancers. Surg. Oncol. 4 (1995) 197-203
30. Langdon S.P., Rabiasz G.J., Hirst G.L., King R.J., Hawkins R.A., Smyth J.F., and Miller W.R. Expression of the heat shock protein HSP27 in human ovarian cancer. Clin. Cancer Res. 1 (1995) 1603-1609
31. Mese H., Sasaki A., Nakayama S., Yoshioka N., Yoshihama Y., Kishimoto K., and Matsumura T. Prognostic significance of heat shock protein 27 (HSP27) in patients with oral squamous cell carcinoma. Oncol. Rep. 9 (2002) 341-344
32. Hsu P.L., and Hsu S.M. Abundance of heat shock proteins (hsp89, hsp60, and hsp27) in malignant cells of Hodgkin's disease. Cancer Res. 58 (1998) 5507-5513
33. Richards E.H., Hickey E., Weber L., and Master J.R. Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells. Cancer Res. 56 (1996) 2446-2451
34. Chauhan D., Li G., Hideshima T., Podar K., Mitsiades C., Mitsiades N., Catley L., Tai Y.T., Hayashi T., Shringarpure R., Burger R., Munshi N., Ohtake Y., Saxena S., and Anderson K.C. Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance. Blood 102 (2003) 3379-3386
35. Landry J., Chretien P., Laszlo A., and Lambert H. Phosphorylation of HSP27 during development and decay of thermotolerance in Chinese hamster cells. J. Cell Physiol. 147 (1991) 93-101
36. Samejima K., Svingen P.A., Basi G.S., Kottke T., Mesner Jr. P.W., Stewart L., Durrieu F., Poirier G.G., Alnemri E.S., Champoux J.J., Kaufmann S.H., and Earnshaw W.C. Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis. J. Biol. Chem. 274 (1999) 4335-4340
37. Zhang X.W., and Xu B. Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells. Anti-cancer Drug 11 (2000) 747-756
38. Concannon C.G., Orrenius S., and Samali A. Hsp27 inhibits cytochrome c-mediated caspase activation by sequestering both pro-caspase-3 and cytochrome c. Gene Expression 9 (2001) 195-201
39. Pandey P., Farber R., Nakazawa A., Kumar S., Bharti A., Nalin C., Weichselbaum R., Kufe D., and Kharbanda S. Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene 19 (2000) 1975-1981
40. Paul C., Manero F., Gonin S., Kretz-Remy C., Virot S., and Arrigo A.P. Hsp27 as a negative regulator of cytochrome C release. Mol. Cell. Biol. 22 (2002) 816-834
41. Mehlen P., Kretz-Remy C., Briolay J., Fostan P., Mirault M.E., and Arrigo A.P. Intracellular reactive oxygen species as apparent modulators of heat-shock protein 27 (hsp27) structural organization and phosphorylation in basal and tumour necrosis factor alpha-treated T47D human carcinoma cells. Biochem. J. 312 (1995) 367-375